Trial NCT00095693

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-01457
Secondary IDs: 6608 CDR0000393968 N01CM62206 N01CM62207 NCI-2012-01457 NCI-6608 OSU 0441 OSU-0441 OSU-2004C0068 P30CA016058 U01CA076576

Last trial update was posted on 2014-01-16

MeSH Interventions

Fluorodeoxyglucose F18 Sorafenib

MeSH Conditions

Adenocarcinoma, Follicular Thyroid Cancer, Papillary Thyroid Carcinoma, Anaplastic Thyroid Diseases Thyroid Neoplasms

Other Conditions

Anaplastic Thyroid Cancer Insular Thyroid Cancer Recurrent Thyroid Cancer Stage III Follicular Thyroid Cancer Stage III Papillary Thyroid Cancer Stage IV Follicular Thyroid Cancer Stage IV Papillary Thyroid Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID